Last reviewed · How we verify
NCT05371457
The Influences of Subscapularis Lesion on Ultrasonography and Kinematics in Patients With Shoulder Impingement
trial in Shoulder Impingement Syndrome in 40 participants. Completed in 15 July 2022.
15 June 2022
Quick facts
| Lead sponsor | National Taiwan University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 14 May 2022 |
| Primary completion | 15 June 2022 |
| Estimated completion | 15 July 2022 |
| Sites | 1 location across Taiwan |
Conditions studied
- Shoulder Impingement Syndrome — all drugs for Shoulder Impingement Syndrome →
Sponsor
National Taiwan University Hospital
Who can join
Adults 20 to 60, any sex, with Shoulder Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Subacromial and subcoracoid impingement have been categorized as external impingement, one type of shoulder impingement syndrome (SIS). Differentiation between subacromial impingement and subcoracoid impingement are important in determining the treatment target. The thickness of the coracohumeral ligament (CHL) may affect coracohumeral distance (CHD), which has been suggested as a possible factor in developing subcoracoid impingement with subscapularis (SSC) lesion. Evidence that indicates the existence of abnormal SSC, CHL thickness and CHD in people with SIS is limited. The purposes of the study were (1) to evaluate the correlations between CHL thickness and CHD by using ultrasonography in people with SIS with and without SSC lesion, (2) to examine the difference in SSC/CHL thickness and CHD between people with SIS with and without SSC lesion.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Alteration in coracohumeral ligament and distance in people with symptoms of subcoracoid impingement.
Ting DS, Yang JL, Lin KH, Wang TG, et al · · 2023 · cited 5× · PMID 36683027 · DOI 10.1186/s12891-023-06152-z
Verify or expand the search:
- PubMed search for NCT05371457
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Shoulder Impingement Syndrome
Currently open trials in the same condition.
- NCT07521839 — Title of This Study is to Evaluate the Effects of Abdominal Drawing in Maneuver With Cross Pattern Limb Exercises in Pat · NA · active not recruiting
- NCT07290660 — Graded Motor Imagery and Task-Oriented Exercise in Shoulder Impingement · NA · recruiting
- NCT07228936 — The Role of Pectoralis Minor Tightness in the Development of Rotator Cuff Tears · recruiting
- NCT06732570 — Effect of High Intensity Laser on Shoulder Impingement. · NA · active not recruiting
- NCT06407804 — Effects of Thrower's Ten and Routine Physical Therapy in Patients With Shoulder Impingement Syndrome · NA · recruiting
Other National Taiwan University Hospital trials
Trials by the same sponsor.
- NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
- NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
- NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
- NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
- NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05371457 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
- Last refreshed: 18 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05371457.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing